Delivery Order SPE2DB24D2011-SPE2DB25FBPGD

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,155.15 firm fixed-price delivery order is for the procurement of VAXELIS vaccine syringes, with a performance period extending through May 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.96 firm fixed-price delivery order is for the VAXELIS vaccine syringe 0.5ML, with a completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,836.88 firm-fixed-price delivery order is for the procurement of VAXELIS vaccine syringes (0.5 mL) to support military and government healthcare programs. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This $3,586.26 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS Vaccine in 0.5mL vials, with a completion date of May 14, 2024. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Vaxelis vaccine syringes. The $20,279.91 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, delivering pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities. This delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,010.16 firm-fixed-price contract is for the delivery of VAXELIS vaccine vials, with a completion date of July 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of the VAXELIS vaccine syringe 0.5 ML. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.96 firm fixed-price delivery order is for the VAXELIS vaccine syringe 0.5ML, with a period of performance ending on March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBPGD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $6,106.57 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VAXELIS vaccine syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This order will support the delivery of the VAXELIS vaccine to meet the medical needs of military personnel, veterans, and other federal beneficiaries through November 2024.

Generated 2/20/25, 9:15 AM